Navigation Links
Massachusetts Affiliate of Susan G. Komen for the Cure to Spotlight Gaps in Breast Cancer Research
Date:4/9/2008

Komen Massachusetts Affiliate to Convene Leading Researchers to Discuss State of Breast Cancer Research and Public Policies Needed to Find Cures

BOSTON, April 9 /PRNewswire/ -- The Massachusetts Affiliate of Susan G. Komen for the Cure will host a symposium April 10 at Harvard Medical School, featuring some of the nation's best (and locally-based) researchers and health care professionals discussing the recent advances in breast cancer research and the need for more funding to ensure that critical advances in the laboratory reach patients.

(Logo: http://www.newscom.com/cgi-bin/prnh/20070122/NYM084LOGO)

Nationwide, one in eight women will get breast cancer in her lifetime. In 2008, more than 4,000 Massachusetts women will be diagnosed with breast cancer and an estimated 900 will die from the disease. Low income women, minorities and underinsured women are more likely to die from the disease, whereas those with access to early diagnosis have a 98 percent chance for survival.

This event launches Massachusetts' participation in the Komen Community Challenge, a nationwide program to restore the sense of urgency to the breast cancer movement and close the gaps in research, public policy and access to quality care that cause some women to die of the disease more than others.

Event and Media Availability Details

WHEN: Thursday, April 10, 9:30 a.m. - 12:30 p.m.

WHAT: Breast Cancer: Closing the Research Gap Symposium

WHO: - Eric P. Winer, MD, Chief Scientific Advisor, Susan G. Komen for

the Cure and Director, Breast Oncology Center, Dana-Farber

Cancer Institute (keynote)

- Nick Littlefield, Partner, Foley Hoag and former Staff Director

and Chief Counsel for Sen. Edward Kennedy (D-MA)

- Brian K. Gibbs, MD, Director of the Program to Eliminate Health

Disparities, Harvard School of Public Health (moderator)

- Miriam May, Executive Director, Massachusetts Affiliate, Susan

G. Komen for the Cure

- Cindy Geoghegan, Executive Director, Scientific Community

Relations, Susan G. Komen for the Cure

- Judy Garber, MD, MPH, Dana-Farber Cancer Institute

- Steven J. Isakoff, MD, PhD, Massachusetts General Hospital

Cancer Center

- Laura Collins, MD, Beth Israel Hospital

- Jim Michelson, MD, Massachusetts General Hospital

- Margaret Barton Burke, PhD, RN, University of Massachusetts

Amherst

- Erin DeRosa, breast cancer survivor

WHERE: Joseph B. Martin Conference Center at Harvard Medical School

77 Avenue Louis Pasteur (across the street from Boston Latin

School)


'/>"/>
SOURCE Susan G. Komen for the Cure
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Massachusetts Health Quality Partners Issues 2008 Report on Quality of Care
2. Comprehensive Pharmacy Services Awarded $80 Million Dollar Pharmacy Services Contract for the State of Massachusetts
3. Blue Cross Blue Shield of Massachusetts and Interwoven to Present at 2008 AIIM International Exposition and Conference
4. Successful Massachusetts Healthcare Reform Initiative Faces Rising Healthcare Costs in Year Two
5. Healing Our Land, Inc. and The Massachusetts Black Legislative Caucus Convene Prevention Is Power Community Forum on the Impact of HIV/AIDS on Communities of Color in Massachusetts
6. Board Members of Five Massachusetts Companies Should Use Sarbanes-Oxley Disclosure Rules in Non-Profit Role, Asserts 1199 SEIU
7. Innovative eHealth Course to Take Place March 28-30 in Boston, Massachusetts
8. Survey: Massachusetts Employers, Employees Paying Most for Health Care Plans
9. Cost of Massachusetts Health Insurance Mandate to Rise 85% -- $400 Mil -- in 09; CA Mandate Proposal Certain to Face Similar Increases
10. Uninsured Massachusetts Consumer Who Cannot Afford Mandatory Purchase of Health Insurance Flies 3,000 Miles to Speak Out; Is Thrown Out Of Capitol By Speaker Nunez
11. Massachusetts Teacher Facing Unaffordable Mandatory Health Insurance Speaks Out Against CA Mandate Proposal
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/22/2017)... VEGAS, NEV. (PRWEB) , ... August 22, 2017 ... ... American Academy of Anti-Aging Medicine recently spoke at a popular international aesthetics conference ... therapy has had on restoring his patients’ health and his growing practice. , ...
(Date:8/22/2017)... ... August 22, 2017 , ... Five Star Glass is new to the Texas market, ... replacement of auto glass for most makes and models, in Grand Prairie, TX, located in ... , They have been a family owned business for the past 40 years with 32 ...
(Date:8/22/2017)... ... August 22, 2017 , ... “Glimpses Of Light”: is a unique ... Of Light” is the creation of published author, J.M. Shepherd, a writer, teacher, traveler, ... to life’s perplexing mysteries. , Shepherd shares, “Love is one of the least understood ...
(Date:8/21/2017)... ... 22, 2017 , ... PracticeMatch, a company that provides online resources , ... and advanced practitioners like nurse practitioners and physician assistants , will ... of this year. The online career fairs will allow job seekers to connect with ...
(Date:8/21/2017)... (PRWEB) , ... August 21, 2017 , ... ... today announced that it has become the Official Technology Partner of North Country ... AES (Advanced Event Systems) volleyball software, along with providing sport management software ...
Breaking Medicine News(10 mins):
(Date:7/28/2017)... Hill-Rom Holdings, Inc. ("Hill-Rom") (NYSE: HRC), today ... June 30, 2017, and updated its financial outlook for ... For the fiscal third quarter, Hill-Rom reported earnings of ... share in the prior-year period. These results reflect after-tax ... share primarily related to the non-cash write-down of assets ...
(Date:7/27/2017)...  West Pharmaceutical Services, Inc. (NYSE: WST ... 2017 and updated financial guidance for the full-year 2017. ... Reported net sales of $397.6 million, ... Net sales at constant currency (organic) grew by 3.9%. ... compared to $0.60 in the prior-year quarter. Second-quarter 2017 ...
(Date:7/26/2017)... , July 26, 2017 Sancilio Pharmaceuticals Company, ... our clinical trial evaluating Altemia TM , an oral ... and Sickle Cell Disease (SCD). The SCOT Trial, is ... efficacy and safety of Altemia TM in pediatric ... under US IND 125274. ...
Breaking Medicine Technology: